As of 2025-05-21, the EV/EBITDA ratio of Selvas Healthcare Inc (208370.KQ) is 24.81. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 208370.KQ's latest enterprise value is 110,466.40 mil KRW. 208370.KQ's TTM EBITDA according to its financial statements is 4,452.52 mil KRW. Dividing these 2 quantities gives us the above 208370.KQ EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 13.0x - 16.5x | 14.2x |
| Forward P/E multiples | 11.1x - 15.8x | 13.0x |
| Fair Price | 2,089.97 - 3,269.10 | 2,622.84 |
| Upside | -55.6% - -30.6% | -44.3% |
| Date | EV/EBITDA |
| 2025-05-02 | 24.43 |
| 2025-04-30 | 24.38 |
| 2025-04-29 | 24.81 |
| 2025-04-28 | 24.23 |
| 2025-04-25 | 24.46 |
| 2025-04-24 | 24.93 |
| 2025-04-23 | 25.27 |
| 2025-04-22 | 25.79 |
| 2025-04-21 | 26.83 |
| 2025-04-18 | 26.20 |
| 2025-04-17 | 24.55 |
| 2025-04-16 | 24.49 |
| 2025-04-15 | 24.84 |
| 2025-04-14 | 24.78 |
| 2025-04-11 | 23.54 |
| 2025-04-10 | 22.06 |
| 2025-04-09 | 20.65 |
| 2025-04-08 | 20.56 |
| 2025-04-07 | 20.65 |
| 2025-04-04 | 21.89 |
| 2025-04-03 | 21.57 |
| 2025-04-02 | 21.17 |
| 2025-04-01 | 21.75 |
| 2025-03-31 | 20.88 |
| 2025-03-28 | 22.01 |
| 2025-03-27 | 22.50 |
| 2025-03-26 | 22.79 |
| 2025-03-25 | 22.58 |
| 2025-03-24 | 22.56 |
| 2025-03-21 | 22.18 |
| 2025-03-20 | 22.64 |
| 2025-03-19 | 23.34 |
| 2025-03-18 | 23.48 |
| 2025-03-17 | 23.34 |
| 2025-03-14 | 23.48 |
| 2025-03-13 | 22.90 |
| 2025-03-12 | 23.05 |
| 2025-03-11 | 22.87 |
| 2025-03-10 | 23.62 |
| 2025-03-07 | 23.71 |
| 2025-03-06 | 24.43 |
| 2025-03-05 | 25.16 |
| 2025-03-04 | 24.12 |
| 2025-02-28 | 24.52 |
| 2025-02-27 | 24.98 |
| 2025-02-26 | 25.53 |
| 2025-02-25 | 25.73 |
| 2025-02-24 | 26.60 |
| 2025-02-21 | 26.08 |
| 2025-02-20 | 25.36 |